• Research and Development

  New Potential IPF Treatment on the FDA’s Fast Track

  Posted by Pulmonary Fibrosis News Moderator on September 18, 2018 at 2:24 pm

  The FDA recently made the decision to grant fast track designation to pamrevlumab, a potential therapy for patients with IPF. Click here to find out more about this exciting new treatment option.

  What do you think about this news?

  replied 6 years, 4 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply